REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 212 filers reported holding REATA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,216,266 | +198.0% | 24,376 | +24.5% | 0.01% | +300.0% |
| Q4 2022 | $743,616 | +38.0% | 19,574 | +10.4% | 0.00% | +100.0% |
| Q2 2022 | $539,000 | -8.0% | 17,725 | +194.7% | 0.00% | -50.0% |
| Q3 2020 | $586,000 | +2690.5% | 6,015 | +4019.9% | 0.00% | – |
| Q1 2020 | $21,000 | -94.3% | 146 | -91.9% | 0.00% | -100.0% |
| Q4 2019 | $371,000 | +1586.4% | 1,813 | +574.0% | 0.00% | – |
| Q3 2019 | $22,000 | -46.3% | 269 | -38.6% | 0.00% | – |
| Q2 2019 | $41,000 | +10.8% | 438 | 0.0% | 0.00% | – |
| Q1 2019 | $37,000 | +1750.0% | 438 | +338.0% | 0.00% | – |
| Q1 2018 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |